纳斯达克生物科技指数表现 - 纳斯达克生物科技指数收涨1.56%，报4,260.4点，上涨65.2点 [1][3] 涨幅显著的成分股 - Sutro Biopharma收涨20.04%，报1.050美元，交易量2.92M [3] - Mersana Therapeutics涨17.19%，报0.433美元，交易量3.24M [1][3] - Neurogene涨15.12%，报15.000美元，交易量168.81K [1][3] - Kyverna Therapeutics涨13.24%，报2.31美元，交易量240.01K [3] - Sana Biotechnology涨11.11%，报1.90美元，交易量2.83M [3] - Larimar Therapeutics Inc涨10.88%，报2.650美元，交易量3.49M [3] - Design Therapeutics涨10.71%，报4.860美元，交易量306.12K [3] - Lexeo Therapeutics涨10.08%，报3.93美元，交易量898.98K [3] 跌幅显著的成分股 - OmniAb跌8.11%，报1.700美元，交易量6.23M [2][3] - Grail跌6.28%，报34.49美元，交易量1.02M [2][3] - Prothena Plc跌5.06%，报9.20美元，交易量969.47K [2][3] - Tempus AI跌4.83%，报51.67美元，交易量7.85M [2][3] - Guardant Health跌4.76%，报47.17美元，交易量3.24M [3] - Biomea Fusion跌4.55%，报2.10美元，交易量629.34K [3] - Mesoblast跌4.28%，报11.400美元，交易量92.79K [3] - SIGA Tech跌4.17%，报5.520美元，交易量451.67K [3]